Sort   by:  
 Page size 
Upon axonal injury, Sterile alpha (SAM) and Toll/interleukin-1 receptor (TIR) motif containing 1 (SARM1) is activated by nicotinamide mononucleotide (NMN) to deplete NAD and consequently promote the process of axon degeneration (AxD). Currently, only the inactive form of SARM1 in its auto-inhibitory...
ORGANISM(S): Homo sapiens (Human) 
2022-11-29 | PXD033528 | Pride
Macrophage depletion blocks congenital SARM1-dependent neuropathy
The NAD hydrolase (NADase) SARM1 acts as a central executioner of programmed axon death and is a possible therapeutic target for neurodegenerative disorders. While orthosteric inhibitors of SARM1 have been described, this multi-domain enzyme is also subject to intricate forms of autoregulation, sugg...
ORGANISM(S): Homo sapiens (Human) 
2022-08-22 | PXD035400 | Pride
Sarm1 knockout prevents type 1 diabetic bone disease in females independent of neuropathy
Effect of SARM1 deficiency on mouse brain transcriptome with or without prion infection
Axon loss contributes to many common neurodegenerative disorders. In healthy axons, the axon survival factor NMNAT2 inhibits SARM1, the central executioner of programmed axon degeneration. We identified two rare NMNAT2 missense variants in two brothers afflicted with a progressive neuropathy syndrom...
ORGANISM(S): Mus musculus 
2022-10-25 | GSE210403 | GEO
Loss of Sarm1 Mitigates Axonal Degeneration and Promotes Neuronal Regeneration After Ischemic Stroke
scRNA-seq of wild type and Sarm1-/- GBM mouse models
Sort   by:  
 Page size